Massive layoffs planned in Pharma?

Press release? There was no press release for this...

Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth

by john carroll — on May 18, 2017 01:19 PM EDT

Novartis is taking out the ax again in its ongoing global reorganization, cutting into its R&D group while making room for hundreds of new hires. Following an overhaul that was focused on the US and Asia last year, it’s the Basel campus that’s getting a makeover now.

Up to 500 jobs in Novartis’ drug development, “traditional” manufacturing and coordination group are being scrapped, with the staffers either being laid off, retiring early or moving to other locations. Moving into the company will be 350 new employees for “high-tech” positions in Switzerland, also for drug development as well as “innovative” biologics manufacturing.

You can file this latest round of cuts and growth to a decision the company made last year to improve operations and increase efficiency, a regular theme at the Swiss multinational. This time around R&D has come under intense focus.

Last summer the urge to streamline operations led Novartis to scrap a 400-person cell and gene therapy unit, integrating it back into its overall development operations and cutting 120 positions. Then in the fall the company made several broad moves, adding new research operations based in Cambridge, MA as well as Basel while shuttering two units in China and Switzerland and relocating another from Singapore to the Bay Area.
 




Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth

by john carroll — on May 18, 2017 01:19 PM EDT

Novartis is taking out the ax again in its ongoing global reorganization, cutting into its R&D group while making room for hundreds of new hires. Following an overhaul that was focused on the US and Asia last year, it’s the Basel campus that’s getting a makeover now.

Up to 500 jobs in Novartis’ drug development, “traditional” manufacturing and coordination group are being scrapped, with the staffers either being laid off, retiring early or moving to other locations. Moving into the company will be 350 new employees for “high-tech” positions in Switzerland, also for drug development as well as “innovative” biologics manufacturing.

You can file this latest round of cuts and growth to a decision the company made last year to improve operations and increase efficiency, a regular theme at the Swiss multinational. This time around R&D has come under intense focus.

Last summer the urge to streamline operations led Novartis to scrap a 400-person cell and gene therapy unit, integrating it back into its overall development operations and cutting 120 positions. Then in the fall the company made several broad moves, adding new research operations based in Cambridge, MA as well as Basel while shuttering two units in China and Switzerland and relocating another from Singapore to the Bay Area.


Apparently reading isn't your strong suit. Are you one of our colleagues in India?? Because your reading comprehension skills would suggest such. That is NOT the press release for the layoffs of DM and Stats Programming that are being shipped to Hydera-bad.

That article CLEARLY states "Following an overhaul that was focused on the US and Asia last year, it’s the Basel campus that’s getting a makeover now." It does not address that ALL DM and Stats Programming in the United States will be offshored to save mone..., err, uhm, I mean make operations more efficient.

Unless you can explain this to me, I stand by my statement that there was no press release. These are two separate things.
 




































http://www.business-standard.com/ar...ndas-pai-shaw-slam-report-117042100593_1.html

And we just sent our remaining programming and DM to India.

Gotta help their villages full of half trained idiots back home get jobs. Can't wait to see this all crash and burn. Our fearless leaders up top will then blame something else while we fall further and further behind the competition.

You should hear the way our study PIs talk about working with our systems.
 




If the article is somehow close to the truth, Novartis just hired 110 "Senior programmers", so out of these 110, 6 should be able to write some code... Luckily, they are quite good at copy/pasting, this smoke screen might work for 4-5 months, and then the ship will sink, and Vas Narasimham will probably blame the weather

Of course Basel and US staff will watch and laugh, can't wait to hear about the submissions fucked up...